Ifosfamide is positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. It is a synthetic analogue of the nitrogen mustard cyclophosphamide with antineoplastic activity. Ifosfamide alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication. This agent is a prodrug that must be activated through hydroxylation by hepatic microsomal enzymes. Ifosfamide is used in the treatment of several forms of cancer including lymphomas, sarcoma and advanced forms of solid organ cancer such as breast, testicular, ovarian, gastric and lung cancer. Ifosfamide therapy is associated with minor transient serum enzyme elevations and has been linked to cases of acute liver injury, including acute cholestatic hepatitis and veno-occlusive disease. The report focuses on the Ifosfamide (CAS 3778-73-2) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Ifosfamide (CAS 3778-73-2) market. Major Players in the Ifosfamide (CAS 3778-73-2) market are: APP Nanjing Cuccess Pharmaceutical Co Ltd Korea United Pharma Stada Cryopharma Teva Hengrui Pisa Delta Farma Alkem ASTA Medica Laboratorio LKM EG Labo Baxter Zydus Sanfer Laboratorio Kampar On the basis of types, the Ifosfamide (CAS 3778-73-2) market is primarily split into: API（Active Pharmaceutical Ingredients） Preparation On the basis of applications, the market covers: Lymphomas Sarcoma Solid organ cancer Major Regions or countries covered in this report: United States Europe China Japan India Southeast Asia Latin America Middle East and Africa Others Years considered for this report: Historical Years: 2017-2021 Base Year: 2021 Estimated Year: 2022 Forecast Period: 2022-2029
Table of Content 1 Ifosfamide (CAS 3778-73-2) Market Overview 1.1 Product Overview and Scope of Ifosfamide (CAS 3778-73-2) Market 1.2 Ifosfamide (CAS 3778-73-2) Market Segment by Type 1.2.1 Global Ifosfamide (CAS 3778-73-2) Market Sales and CAGR (%) Comparison by Type (2017-2029) 1.3 Global Ifosfamide (CAS 3778-73-2) Market Segment by Application 1.3.1 Ifosfamide (CAS 3778-73-2) Market Consumptio
